Investor Relations

Investor Presentation

View our latest Investor Presentation to find the most recent investor-related information.

Investor Relations

Latest Presentation

Investor Presentation

Company Overview

Virax Biolabs Group Limited is an innovative biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. In addition to distributing an array of in-vitro diagnostic test kits, Virax Biolabs Group Limited is currently developing T-cell based test technologies with the intention of providing an immunology profiling platform. T-cell testing can be particularly effective in the diagnosis and therapeutics of Long COVID as well as chronic inflammation and other post viral syndromes including myalgic encephalomyelitis, Hepaitis B, Malaria, Herpes and Human Papillomavirus.

IR Contacts

Headquarters

Virax Biolabs Group Limited
BioCity Glasgow
Bo’Ness Road, Newhouse
Lanarkshire ML1 5UH
United Kingdom
T: +44 20 7788 7414
info@viraxbiolabs.com

Investor Relations

Russo Partners, LLC
Nic Johnson and Adanna Alexander
12 West 27th Street
4th Floor
New York, NY 10001
M: 303-482-6405
nic.johnson@russopartnersllc.com

Transfer Agent

Continental Stock Transfer
Vito Cirone
1 State Street
30th Floor
New York, NY 10004
vcirone@continentalstock.com